Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)
Clinical trial NCT05850507 · COMPLETED
Trial details
- NCT number
- NCT05850507
- Sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-17
- Primary completion
- 2023-10-17
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.